The meeting has resumed.
I'd like to welcome back everyone to meeting number 31 of the House of Commons Standing Committee on Health. Pursuant to the order of reference of May 26, 2020, we are continuing a briefing on the Canadian response to the outbreak of the coronavirus.
I'd like to make a few comments for the benefit of the new witnesses. Before speaking, please wait until I recognize you by name, except during questioning. I'll ask the questioners to indicate whom they wish to respond to the question. When you're ready to speak, you can click on the microphone icon to activate your mike. I remind you that all comments should be addressed through the chair.
Interpretation in this video conference will work very much like in a regular committee meeting. You have a choice, at the bottom of your screen, of floor, English or French. As you are speaking, if you plan to alternate from one language to the other, you will need to switch the interpretation channel so it aligns with the language you are speaking. You may want to allow for a short pause when switching languages.
When you're not speaking, your mike should be on mute.
I'd like now to welcome our second panel of witnesses. Appearing as an individual we have Mario Possamai, who was senior advisor, Commission to Investigate the Introduction and Spread of Severe Acute Respiratory Syndrome, 2003-07; for Mapsted, we have Paramvir Nagpal, founder and chief executive officer; for Medtronic Canada, we have Patrick Hupé, senior director, health systems strategies.
I will ask the panellists to make their statements. Each group will have up to 10 minutes.
We'll start with Mr. Possamai. Please go ahead.